Majid Zeinali
- Molecular Biology
- Pharmacology top 10%
- Oncology
- Plant Science
- Complementary and alternative medicine top 10%
- Co-authors
- Hossein HosseinzadehSeyed Abdolrahim RezaeeMohammad Reza ZirakGholamreza KarimiKamal Razavi-AzarkhiaviSoghra MehriA. Wallace HayesFatemeh Tavakoli
- Topics
- Retinoids in leukemia and cellular processes (3 papers)Cancer Research and Treatment (2 papers)Nanoparticle-Based Drug Delivery (2 papers)
- Journals
- SHILAP Revista de lepidopterologíaScientific ReportsFood and Chemical Toxicology
- Partner nations
- IranNetherlandsNigeria
In The Last Decade
Majid Zeinali
14 papers receiving 500 citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 148
- Pharmacology 105
- Oncology 100
- Plant Science 68
- Complementary and alternative medicine 65
Countries citing papers authored by Majid Zeinali
This map shows the geographic impact of Majid Zeinali's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Majid Zeinali with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Majid Zeinali more than expected).
Fields of papers citing papers by Majid Zeinali
This network shows the impact of papers produced by Majid Zeinali. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Majid Zeinali. The network helps show where Majid Zeinali may publish in the future.
Co-authorship network of co-authors of Majid Zeinali
This figure shows the co-authorship network connecting the top 25 collaborators of Majid Zeinali. A scholar is included among the top collaborators of Majid Zeinali based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Majid Zeinali. Majid Zeinali is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 21 | |
| 3 | 1 | |
| 4 | 50 | |
| 5 | 101 | |
| 6 | 34 | |
| 7 | 169 | |
| 8 | 14 | |
| 9 | 16 | |
| 10 | A Comparative Cytotoxicity Study of Doxorubicin Loaded PLGA, P (NIPAAm-MAA-DMAEMA) and Solid Lipid Nanoparticles as Anticancer Drug Delivery Systems | 5 |
| 11 | 18 | |
| 12 | 10 | |
| 13 | 52 | |
| 14 | 6 | |
| 15 | 1 |
About Majid Zeinali
Majid Zeinali is a scholar working on Complementary and Manual Therapy, Pharmacology and Toxicology, having authored 15 papers that have together received 506 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (3 papers), Cancer Research and Treatment (2 papers) and Nanoparticle-Based Drug Delivery (2 papers). The work is most often cited by research in Biochemistry (51 citations), Complementary and alternative medicine (65 citations) and Pharmacology (60 citations). Majid Zeinali has collaborated with scholars based in Iran, Netherlands and Nigeria. Frequent co-authors include Hossein Hosseinzadeh, Seyed Abdolrahim Rezaee, Mohammad Reza Zirak, Gholamreza Karimi, Kamal Razavi-Azarkhiavi, Soghra Mehri, A. Wallace Hayes, Fatemeh Tavakoli, Shokoufeh Hassani and Mohammad Reza Sepand. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Food and Chemical Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.